6.12 USD
▲+0.21+1.16%
2026-08-03
市值
$403.03M
市盈率
—
EPS
-0.67
股息率
—
52 周区间
3.86 – 9.35
成交量
668.34K
Beta
1.32
目标价
14.67
52W 低 3.8652W 高 9.35
价格走势
公司简介
Evolus, Inc., a performance beauty company, delivers products in the cash-pay aesthetic market in the United States, Canada, Europe, and Australia. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults; and Evolysse, a collection of injectable hyaluronic acid gels, which includes various products, such as mid face, nasolabial folds, lips and eyes. The company was incorporated in 2012 and is headquartered in Newpo...